Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.
Bromodomains, protein modules that recognize and bind to acetylated lysine, are emerging as important components of cellular machinery. These acetyl-lysine (KAc) "reader" domains are part of the write-read-erase concept that has been linked with the transfer of epigenetic information. By r...
Main Authors: | , , , , , , , |
---|---|
格式: | Journal article |
语言: | English |
出版: |
2012
|
_version_ | 1826281429917499392 |
---|---|
author | Hewings, D Rooney, T Jennings, L Hay, D Schofield, C Brennan, P Knapp, S Conway, S |
author_facet | Hewings, D Rooney, T Jennings, L Hay, D Schofield, C Brennan, P Knapp, S Conway, S |
author_sort | Hewings, D |
collection | OXFORD |
description | Bromodomains, protein modules that recognize and bind to acetylated lysine, are emerging as important components of cellular machinery. These acetyl-lysine (KAc) "reader" domains are part of the write-read-erase concept that has been linked with the transfer of epigenetic information. By reading KAc marks on histones, bromodomains mediate protein-protein interactions between a diverse array of partners. There has been intense activity in developing potent and selective small molecule probes that disrupt the interaction between a given bromodomain and KAc. Rapid success has been achieved with the BET family of bromodomains, and a number of potent and selective probes have been reported. These compounds have enabled linking of the BET bromodomains with diseases, including cancer and inflammation, suggesting that bromodomains are druggable targets. Herein, we review the biology of the bromodomains and discuss the SAR for the existing small molecule probes. The biology that has been enabled by these compounds is summarized. |
first_indexed | 2024-03-07T00:28:40Z |
format | Journal article |
id | oxford-uuid:7f054681-270a-4838-b674-c656370fa6cf |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T00:28:40Z |
publishDate | 2012 |
record_format | dspace |
spelling | oxford-uuid:7f054681-270a-4838-b674-c656370fa6cf2022-03-26T21:14:04ZProgress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7f054681-270a-4838-b674-c656370fa6cfEnglishSymplectic Elements at Oxford2012Hewings, DRooney, TJennings, LHay, DSchofield, CBrennan, PKnapp, SConway, SBromodomains, protein modules that recognize and bind to acetylated lysine, are emerging as important components of cellular machinery. These acetyl-lysine (KAc) "reader" domains are part of the write-read-erase concept that has been linked with the transfer of epigenetic information. By reading KAc marks on histones, bromodomains mediate protein-protein interactions between a diverse array of partners. There has been intense activity in developing potent and selective small molecule probes that disrupt the interaction between a given bromodomain and KAc. Rapid success has been achieved with the BET family of bromodomains, and a number of potent and selective probes have been reported. These compounds have enabled linking of the BET bromodomains with diseases, including cancer and inflammation, suggesting that bromodomains are druggable targets. Herein, we review the biology of the bromodomains and discuss the SAR for the existing small molecule probes. The biology that has been enabled by these compounds is summarized. |
spellingShingle | Hewings, D Rooney, T Jennings, L Hay, D Schofield, C Brennan, P Knapp, S Conway, S Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions. |
title | Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions. |
title_full | Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions. |
title_fullStr | Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions. |
title_full_unstemmed | Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions. |
title_short | Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions. |
title_sort | progress in the development and application of small molecule inhibitors of bromodomain acetyl lysine interactions |
work_keys_str_mv | AT hewingsd progressinthedevelopmentandapplicationofsmallmoleculeinhibitorsofbromodomainacetyllysineinteractions AT rooneyt progressinthedevelopmentandapplicationofsmallmoleculeinhibitorsofbromodomainacetyllysineinteractions AT jenningsl progressinthedevelopmentandapplicationofsmallmoleculeinhibitorsofbromodomainacetyllysineinteractions AT hayd progressinthedevelopmentandapplicationofsmallmoleculeinhibitorsofbromodomainacetyllysineinteractions AT schofieldc progressinthedevelopmentandapplicationofsmallmoleculeinhibitorsofbromodomainacetyllysineinteractions AT brennanp progressinthedevelopmentandapplicationofsmallmoleculeinhibitorsofbromodomainacetyllysineinteractions AT knapps progressinthedevelopmentandapplicationofsmallmoleculeinhibitorsofbromodomainacetyllysineinteractions AT conways progressinthedevelopmentandapplicationofsmallmoleculeinhibitorsofbromodomainacetyllysineinteractions |